Ad
BOLD - Audentes Therapeutics Stock Trading
About | Audentes Therapeutics Inc. (NASDAQ:BOLD)
Not available
Quote | Audentes Therapeutics Inc. (NASDAQ:BOLD)
| Last: | $ |
|---|---|
| Change Percent: | -4.59% |
| Open: | $28.62 |
| Close: | $27.41 |
| High: | $28.66 |
| Low: | $27.31 |
| Volume: | 422,095 |
| Last Trade Date Time: | 10/15/2019 07:27:07 am |
News | Audentes Therapeutics Inc. (NASDAQ:BOLD)
-
Natural gas has been one of the worst-performing commodities over the last decade. However, the fundamentals are improving due to demand improving, and production being depressed. Reason one- Georgia will determine US energy policy Reason two- The rig count is low while the dema...
-
Satsuma Pharmaceuticals ( STSA -0.3% ) appointed industry veteran Thomas M. Soloway, currently serving as EVP and COO of Audentes Therapeutics ( BOLD ), to its board of directors, effective July 2, 2020. More news on: Satsuma Pharmaceuticals, Inc., Audentes Therapeutics, Inc., Asc...
Message Board Posts | Audentes Therapeutics Inc. (NASDAQ:BOLD)
| Subject | By | Source | When |
|---|---|---|---|
| No posts yet. | |||
Audentes Therapeutics Inc. Company Name:
BOLD Stock Symbol:
NASDAQ Market:
Audentes Therapeutics Inc. Website:
Ad
-
Natural gas has been one of the worst-performing commodities over the last decade. However, the fundamentals are improving due to demand improving, and production being depressed. Reason one- Georgia will determine US energy policy Reason two- The rig count is low while the dema...
-
Broadly, genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche li...
-
NEW YORK, NY / ACCESSWIRE / January 3, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: MSB Financial Corp. (NASDAQ: MSBF ) ("MSB F...